BRPI0412240A - sistema terapêutico transdérmico com a substáncia ativa pramipexol - Google Patents
sistema terapêutico transdérmico com a substáncia ativa pramipexolInfo
- Publication number
- BRPI0412240A BRPI0412240A BRPI0412240-2A BRPI0412240A BRPI0412240A BR PI0412240 A BRPI0412240 A BR PI0412240A BR PI0412240 A BRPI0412240 A BR PI0412240A BR PI0412240 A BRPI0412240 A BR PI0412240A
- Authority
- BR
- Brazil
- Prior art keywords
- active substance
- therapeutic system
- transdermal therapeutic
- pramipexole
- transdermal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10333393A DE10333393A1 (de) | 2003-07-23 | 2003-07-23 | Transdermales Therapeutisches System mit dem Wirkstoff Pramipexol |
| PCT/EP2004/007770 WO2005011687A1 (de) | 2003-07-23 | 2004-07-14 | Transdermales therapeutisches system mit dem wirkstoff pramipexol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0412240A true BRPI0412240A (pt) | 2006-09-12 |
Family
ID=34088745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0412240-2A BRPI0412240A (pt) | 2003-07-23 | 2004-07-14 | sistema terapêutico transdérmico com a substáncia ativa pramipexol |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20060182791A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1651215A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4925823B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20060113638A (cg-RX-API-DMAC7.html) |
| CN (1) | CN100450482C (cg-RX-API-DMAC7.html) |
| AU (1) | AU2004260583B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0412240A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2532904A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE10333393A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005011687A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200600206B (cg-RX-API-DMAC7.html) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE444750T1 (de) * | 2005-08-15 | 2009-10-15 | Univ Virginia | Neurorestauration mit r(+) pramipexol |
| US8518926B2 (en) | 2006-04-10 | 2013-08-27 | Knopp Neurosciences, Inc. | Compositions and methods of using (R)-pramipexole |
| CN102160865A (zh) | 2006-05-16 | 2011-08-24 | 诺普神经科学股份有限公司 | R(+)和s(-)普拉克索的组合物以及使用该组合物的方法 |
| WO2008001200A2 (en) * | 2006-06-29 | 2008-01-03 | Antares Pharma Ipl Ag | Transdermal composition having enhanced color stability |
| US20080254118A1 (en) * | 2007-04-11 | 2008-10-16 | Hans-Werner Wernersbach | Process for preparing pramipexole dihydrochloride tablets |
| US8524695B2 (en) | 2006-12-14 | 2013-09-03 | Knopp Neurosciences, Inc. | Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same |
| CN101677564A (zh) * | 2007-03-14 | 2010-03-24 | 诺普神经科学股份有限公司 | (6r)-4,5,6,7-四氢-n6-丙基-2,6-苯并噻唑-二胺的改良释放制剂及其使用方法 |
| US8519148B2 (en) | 2007-03-14 | 2013-08-27 | Knopp Neurosciences, Inc. | Synthesis of chirally purified substituted benzothiazole diamines |
| US20080254117A1 (en) * | 2007-04-10 | 2008-10-16 | Noel Cotton | Process for preparing pramipexole dihydrochloride tablets |
| WO2010010141A1 (en) * | 2008-07-25 | 2010-01-28 | Boehringer Ingelheim International Gmbh | Pramipexole for treating cardiomyopathy |
| JP2012500283A (ja) | 2008-08-19 | 2012-01-05 | ノップ ニューロサイエンシーズ、インク. | (r)−プラミペキソールを使用した組成物並びにその方法 |
| JP5652867B2 (ja) * | 2009-11-20 | 2015-01-14 | 日東電工株式会社 | 医療用粘着剤組成物 |
| JP5665116B2 (ja) * | 2009-11-20 | 2015-02-04 | 日東電工株式会社 | 貼付剤および貼付製剤 |
| WO2013096816A1 (en) | 2011-12-22 | 2013-06-27 | Biogen Idec Ma Inc. | Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds |
| DE102012205493A1 (de) | 2012-04-03 | 2013-10-10 | Acino Ag | Einen Dopamin-Agonisten enthaltendes transdermales Applikationssystem |
| US20140045801A1 (en) * | 2012-08-09 | 2014-02-13 | Mylan Inc. | Pramipexole transdermal delivery for severe headaches |
| US9662313B2 (en) | 2013-02-28 | 2017-05-30 | Knopp Biosciences Llc | Compositions and methods for treating amyotrophic lateral sclerosis in responders |
| US9682068B2 (en) * | 2013-05-20 | 2017-06-20 | Mylan Inc. | Transdermal therapeutic system for extended dosing of pramipexole in treating neurological disorders |
| US9468630B2 (en) | 2013-07-12 | 2016-10-18 | Knopp Biosciences Llc | Compositions and methods for treating conditions related to increased eosinophils |
| RS67279B1 (sr) | 2013-07-12 | 2025-10-31 | Areteia Therapeutics Inc | Lečenje povišenih nivoa eozinofila i/ili bazofila |
| EP3033081B1 (en) | 2013-08-13 | 2021-05-12 | Knopp Biosciences LLC | Compositions and methods for treating chronic urticaria |
| ES2813674T3 (es) | 2013-08-13 | 2021-03-24 | Knopp Biosciences Llc | Composiciones y métodos para el tratamiento de trastornos de células plasmáticas y trastornos prolinfocíticos de células b |
| CN103610666A (zh) * | 2013-12-11 | 2014-03-05 | 中国药科大学 | 一种盐酸普拉克索透皮贴剂及其制备方法 |
| US10045948B2 (en) | 2014-02-27 | 2018-08-14 | Medrx Co., Ltd. | Pramipexole-containing transdermal patch for treatment of neurodegenerative disease |
| US9837244B2 (en) * | 2014-12-26 | 2017-12-05 | Industrial Technology Research Insitute | Sample holding device for studying light-driven reactions and sample analysis method using the same |
| CN104510725B (zh) * | 2015-01-22 | 2021-04-27 | 中国药科大学 | 一种普拉克索周效透皮贴剂及其制备方法 |
| CN114668747A (zh) * | 2016-10-07 | 2022-06-28 | 全崴生技股份有限公司 | 普拉克索经皮贴片系统与用法 |
| CN109999012A (zh) * | 2019-03-26 | 2019-07-12 | 大道隆达(北京)医药科技发展有限公司 | 一种普拉克索透皮贴剂及其制备方法 |
| CN111904950B (zh) * | 2019-05-07 | 2023-05-05 | 上海京新生物医药有限公司 | 一种普拉克索透皮贴剂 |
| CN117860708A (zh) * | 2022-10-11 | 2024-04-12 | 姜钦治 | 含有普拉克索和雷沙吉兰的透皮贴片 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3315272C2 (de) * | 1983-04-27 | 1986-03-27 | Lohmann Gmbh & Co Kg, 5450 Neuwied | Pharmazeutisches Produkt und Verfahren zu seiner Herstellung |
| US5238944A (en) * | 1988-12-15 | 1993-08-24 | Riker Laboratories, Inc. | Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine |
| DE3937271A1 (de) * | 1989-11-09 | 1991-05-16 | Boehringer Ingelheim Kg | Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol |
| US5650420A (en) * | 1994-12-15 | 1997-07-22 | Pharmacia & Upjohn Company | Pramipexole as a neuroprotective agent |
| US5562917A (en) * | 1994-12-23 | 1996-10-08 | Pentech Pharmaceuticals, Inc. | Transdermal administration of apomorphine |
| WO1996040087A2 (en) * | 1995-06-07 | 1996-12-19 | Cygnus, Inc. | Pressure sensitive acrylate adhesive composition cross-linked with aluminum acetylacetonate and containing a drug having a reactive aromatic hydroxyl group |
| US6365178B1 (en) * | 1996-09-06 | 2002-04-02 | Watson Pharmaceuticals, Inc. | Method of making pressure sensitive adhesive matrix patches for transdermal drug delivery using hydrophilic salts of drugs and hydrophobic pressure sensitive adhesive dispersions |
| US6465004B1 (en) * | 1999-06-05 | 2002-10-15 | Noven Pharmaceuticals, Inc. | Solubility enhancement of drugs in transdermal drug delivery systems and methods of use |
| JP2003512414A (ja) * | 1999-10-28 | 2003-04-02 | スリーエム イノベイティブ プロパティズ カンパニー | 経皮薬物送達装置 |
| DE10033853A1 (de) * | 2000-07-12 | 2002-01-31 | Hexal Ag | Transdermales therapeutisches System mit hochdispersem Siliziumdioxid |
| KR100846642B1 (ko) * | 2001-03-07 | 2008-07-16 | 히사미쓰 세이야꾸 가부시키가이샤 | 첩부제 |
| DE10137082A1 (de) * | 2001-07-28 | 2003-02-13 | Hexal Ag | Matrixkontrolliertes transdermales therapeutisches System zur Anwendung von Pramiprexol und Ropinirol |
| DE10137162A1 (de) * | 2001-07-30 | 2003-02-20 | Hexal Ag | Matrixkontrolliertes transdermales therapeutisches System zur Anwendung von Pramiprexol und Ropinirol |
-
2003
- 2003-07-23 DE DE10333393A patent/DE10333393A1/de not_active Ceased
-
2004
- 2004-07-14 CA CA002532904A patent/CA2532904A1/en not_active Abandoned
- 2004-07-14 US US10/564,932 patent/US20060182791A1/en not_active Abandoned
- 2004-07-14 KR KR1020067001495A patent/KR20060113638A/ko not_active Ceased
- 2004-07-14 WO PCT/EP2004/007770 patent/WO2005011687A1/de not_active Ceased
- 2004-07-14 JP JP2006520736A patent/JP4925823B2/ja not_active Expired - Fee Related
- 2004-07-14 AU AU2004260583A patent/AU2004260583B2/en not_active Ceased
- 2004-07-14 EP EP04740987A patent/EP1651215A1/de not_active Withdrawn
- 2004-07-14 BR BRPI0412240-2A patent/BRPI0412240A/pt not_active IP Right Cessation
- 2004-07-14 CN CNB2004800210396A patent/CN100450482C/zh not_active Expired - Fee Related
-
2006
- 2006-01-09 ZA ZA200600206A patent/ZA200600206B/en unknown
-
2012
- 2012-05-17 US US13/473,724 patent/US20120225103A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE10333393A1 (de) | 2005-02-24 |
| JP4925823B2 (ja) | 2012-05-09 |
| US20060182791A1 (en) | 2006-08-17 |
| KR20060113638A (ko) | 2006-11-02 |
| JP2006528144A (ja) | 2006-12-14 |
| CN100450482C (zh) | 2009-01-14 |
| ZA200600206B (en) | 2007-02-28 |
| AU2004260583A1 (en) | 2005-02-10 |
| US20120225103A1 (en) | 2012-09-06 |
| AU2004260583B2 (en) | 2010-01-28 |
| CN1826113A (zh) | 2006-08-30 |
| CA2532904A1 (en) | 2005-02-10 |
| EP1651215A1 (de) | 2006-05-03 |
| WO2005011687A1 (de) | 2005-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0400350A (pt) | Lancetador compreendendo um sistema de lanceta que é protegido contra reutilização | |
| BR9813360A (pt) | Derivados de ácido hidroxâmico como inibidores de metaloprotease de matriz (mmp) | |
| BRPI0720996B8 (pt) | composição adesiva sensível à pressão contendo sal, construto adesivo em camadas, e, dispositivo médico | |
| UY30274A1 (es) | Derivados sustituidos de la n-(4-metil-1,3-tiazol-2-il)guanidina, formulaciones farmacéuticas conteniéndolo y aplicaciones | |
| DK1418951T3 (da) | Transdermalt teraeutisk system (TTS) med fentanyl som aktiv bestanddel | |
| ATE423525T1 (de) | Reflektorsystem zur positionsbestimmung | |
| DE50311898D1 (de) | Fredericamycin-derivate als arzneimittel zur tumorbehandlung | |
| BR0312729A (pt) | Novos derivados de indol-3-enxofre | |
| UY26659A1 (es) | Heterociclos bicíclicos, medicamentos que contienen estos compuestos, su empleo y procedimientos para su preparación | |
| PT1009393E (pt) | Sistema terapeutico transdermico com camada auto-adesiva tipo reservatorio e camada posterior unidireccionalmente elastica | |
| HN2000000115A (es) | Formulacion de sal comun y moxifloxacina | |
| PL378035A1 (pl) | Transdermalny system terapeutyczny w postaci plastra odporny na działanie promieniowania UV | |
| MA26962A1 (fr) | Derives de benzodiazepine tels que gaba en tant que modulateurs de reception. | |
| ES2169147T3 (es) | Derivados de beta-carbolina agonistas de la melatonina, sus procedimientos de preparacion y su utilizacion a titulo de medicamento. | |
| BRPI0515628A (pt) | composto de 2-morfolina-4-pirimidona | |
| KR950703953A (ko) | 2-아미노-6-n-프로필아미노-4, 5, 6, 7-테트라하이드로벤조티아졸(프라미펙솔)의 항우울제로서의 용도(Use of 2-amino-6-n-propylamino-4, 5, 6, 7-tetrahydrobenzothiazole (pramipexol)as an antidepressant drug) | |
| ECSP088773A (es) | Derivados de amida y su aplicación para el tratamiento de enfermedades relacionadas con proteína-g | |
| CY1110078T1 (el) | Παρασκευασματα με ιωδιουχο ποβιδονη για την αγωγη τραυματων | |
| DE60132011D1 (de) | Nitroderivate als arzneimittel für auf entzündungen beruhende erkrankungen | |
| BR0312362A (pt) | Sola a prova d'água e respirável para calçados, uso de adesivos termorreativos, e, método para produzir uma sola a prova d'água e respirável para calçados | |
| WO2014188329A3 (en) | Transdermal extended dosing of pramipexole for neurological disorders | |
| IT1293974B1 (it) | Dispositivo impiantabile attivo. | |
| BRPI0017528B8 (pt) | uso de uma composição contendo sal de cetotifeno | |
| BR0309558A (pt) | Derivados de quinazolina e medicamentos | |
| BRPI0507982A (pt) | sistema e método para fornecer tratamento a um corpo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE A 8A ANUIDADE. |